Date of Original Version

8-6-2015

Type

Article

PubMed ID

26253199

Rights Management

This is the author’s version of a work that was accepted for publication. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version is available at http://dx.doi.org/10.1016/j.stem.2015.07.016

Abstract or Description

Patient-funded trials (PFTs) are gaining traction as a means of accelerating clinical translation. However, such trials sidestep mechanisms that promote rigor, relevance, efficiency, and fairness. We recommend that funding bodies or research institutions establish mechanisms for merit review of patient-funded trials, and we offer some basic criteria for evaluating PFT protocols.

DOI

10.1016/j.stem.2015.07.016

Included in

Philosophy Commons

Share

COinS
 

Published In

Cell Stem Cell, 17, 2, 135-137.